Mostim 24 mg Injection
339,87$
265,10$
Mostim 24 mg Injection is a specialized stem cell mobilizer used in conjunction with granulocyte colony-stimulating factor (G-CSF) to effectively prepare hematopoietic stem cells for transplantation in individuals diagnosed with non-Hodgkin's lymphoma and multiple myeloma. This innovative treatment contains Plerixafor, a member of the haematopoietic stem cell mobilizers class, which functions by targeting the CXCR4 chemokine receptor, thereby preventing the binding of its ligand, CXCL12. This mechanism facilitates the release of stem cells from the bone marrow into the bloodstream, making them more accessible for collection and subsequent transplantation. Patients considering Mostim should be aware of potential side effects, including nausea, diarrhea, and injection site reactions, and should consult their healthcare provider for personalized advice. As a crucial part of cancer treatment, Mostim aids in optimizing the success of stem cell transplants, which can significantly improve outcomes for patients battling these complex blood cancers. Always ensure that you are under the supervision of a qualified healthcare professional when using this medication to mitigate risks and monitor for adverse effects.
Quantité
Active Pharmaceutical Ingredient
Uses
• Mostim 24 mg injection is primarily used to support patients undergoing certain medical procedures that involve blood filtration. By administering Mostim 24 mg injection, healthcare providers can enhance the body's response to treatment. This is particularly beneficial in settings where effective blood filtration is critical. The timing of the injection is crucial, typically given 11 hours prior to the procedure.
• The injection is also utilized in specific therapeutic regimens to optimize patient outcomes during complex treatments. Mostim 24 mg injection can help prepare the body for interventions that require enhanced physiological responses. This can lead to improved efficacy of the overall treatment plan. Medical professionals often assess the patient's condition to determine the appropriate timing and administration of Mostim 24 mg injection.
• Mostim 24 mg injection is indicated for use in patients who may need additional support during their recovery phase. The injection aids in facilitating better healing processes and can be an integral part of postoperative care. By incorporating Mostim 24 mg injection into the recovery plan, healthcare providers aim to enhance overall patient well-being. The administration is typically monitored closely to ensure optimal results.
• In certain cases, Mostim 24 mg injection may be administered as part of a broader treatment strategy in specific clinical settings. This injection serves to bolster the patient's resilience and response to ongoing therapies. The decision to use Mostim 24 mg injection is made by healthcare professionals based on a thorough evaluation of the patient’s needs. Its role in treatment underscores the importance of individualized medical care.
Benefits
Autologous stem cell transplant: This is a procedure in which certain blood cells are removed from the body and then returned to the body after chemotherapy and/or radiation in people with positive cancers. A doctor or nurse will give you this Mostim 24 mg Injection. You should follow your doctor's instructions carefully to get the most benefit from it.
Side Effects
Side effects, which are unwanted symptoms, can be caused by taking medicines. It is important to understand that all medicines have the potential to cause side effects. However, they may not affect everyone who takes them.
Most Common Side Effects
• Constipation
• Nausea
• Dry mouth
• Numbness
• Stomach upset
• Bloating
• Lethargic
• Muscle pain
• Profuse perspiration
• Rashes
Common Side Effects
• Bleeding
• Unusual weakness
• Severe epigastric pain
• Joint pain
• Dizziness
• Burning
• Crawling
• Itching
• Vomiting
• Headache
How To Use
Mostim 24 mg Injection is available in an injectable form. Mostim Injection is given under the skin (subcutaneously) only under medical supervision and as directed by your doctor. Mostim 24 mg Injection is usually given 11 hours before the filtration of the blood. The dose and frequency will be determined by your doctor. It will depend on your medical condition, weight and certain other factors.
Safety Advice
• Alcohol: The safety of the use of alcohol with Mostim Injection is not known. It is advisable to have a discussion with your doctor about this.
• Kidney: Mostim 24 mg Injection must be used with a warning for patients with kidney disease. It may be necessary to adjust the dose of the injection. It is advisable to consult your doctor for further advice.
• Breastfeeding: Mostim 24 mg Injection may be dangerous to use for the duration of breastfeeding. Limited human statistics show that the drug may also pass into breast milk and harm the baby.
• Liver: Mostim 24 mg Injection must be used with a warning for patients with liver disease. It may be necessary to adjust the dose of the injection. It is advisable to consult your doctor for further advice.
• Pregnancy: Mostim 24 mg Injection should not be used during pregnancy. There is strong evidence of a risk to the developing baby. However, it may be prescribed by your doctor in rare, life-threatening situations where the benefits of use outweigh the potential risks.
• Driving: The effect of Mostim 24 mg Injection on the ability to drive a vehicle has not been established. You should not drive if you experience symptoms that impair your concentration and reactions.